ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627745 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627745; 2) Community: the network communities that were significantly associated with the response to NSC 627745; 3) Molecule: the relationships between components within communities and NSC 627745; 4) MDR: the compounds that were significantly associated with the NSC 627745.

NSC Compound Enrichment Correlation
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0016365323975257 0.76384541
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0016365323975257 0.68987583
NSC 625544 Null 0.0016365323975257 0.59932402
NSC 626162 Discorhabdin C . TFA 0.0016365323975257 0.79696784
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0016365323975257 0.75505953
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0016365323975257 -0.31517407
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00163653239752571 0.71326189
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.00163653239752571 0.56781237
NSC 655305 Null 0.00163653239752571 0.81321316
NSC 666034 Carquniostatin B 0.00163653239752571 0.66307135
Total:131  Current:10    [First] [Prev] [Next] [Last]